Event Reports | Infection Update

EVENT REPORTS

Changes and Updates in the New ATS/IDSA 2019 CAP Guidelines

Daiichi Sankyo’s ‘Meet the Expert Online’ webinar, held on 17 March 2021 and presented by Professor Lionel Ari Mandell of McMaster University, Canada, was convened to discuss new updates in...

Daiichi Sankyo’s ‘Meet the Expert Online’ webinar, held on 17 March 2021 and presented by Professor Lionel Ari Mandell of McMaster University, Canada, was convened to discuss new updates in...

The Role of Levofloxacin for the Treatment of Respiratory Tract Infections (Highlights of a Special Roundtable Discussion)

Introduction Pharmacodynamics and Pharmacokinetics of Levofloxacin George L. Drusano, MD Professor and Director Division of Clinical Pharmacology Departments of Medicine and Pharmacology Albany Medical College, Albany, NY, USA Results from...

Introduction Pharmacodynamics and Pharmacokinetics of Levofloxacin George L. Drusano, MD Professor and Director Division of Clinical Pharmacology Departments of Medicine and Pharmacology Albany Medical College, Albany, NY, USA Results from...

New Insights in the Treatment of Severe Infections in the Multiple-Drug Resistant Situation (Highlights of the Daiichi Pharmaceutical Co., Ltd. Satellite Symposium to the 11th International Congress on Infectious Diseases)

Introduction Comparative Antimicrobial Susceptibility of Respiratory Tract Pathogens David Felmingham, BSc MSc Dip LSHTM Chief Executive , GR Micro Ltd, London, UK Honorary Senior Lecturer London School of Hygiene and...

Introduction Comparative Antimicrobial Susceptibility of Respiratory Tract Pathogens David Felmingham, BSc MSc Dip LSHTM Chief Executive , GR Micro Ltd, London, UK Honorary Senior Lecturer London School of Hygiene and...

Levofloxacin Stands Above the Rest: A Fluoroquinolone with Both Efficacy and Safety (Highlights of a Special Roundtable Discussion)

Introduction Antimicrobial Resistance Among Streptococcus Pneumoniae: Implications for Therapy Joseph P. Lynch, III Associate Chief Division of Pulmonary and Critical Care Medicine David Geffen School of Medicine at UCLA Los...

Introduction Antimicrobial Resistance Among Streptococcus Pneumoniae: Implications for Therapy Joseph P. Lynch, III Associate Chief Division of Pulmonary and Critical Care Medicine David Geffen School of Medicine at UCLA Los...

Safety Assessment of Antimicrobial Agents: Criteria for the Balance Between Efficacy and Safety (Aventis Pharma/Daiichi Pharmaceutical Co. Ltd./ Ortho-McNeil Pharmaceutical Inc. Joint-Sponsored Symposium At the 22nd International Congress of Chemotherapy)

Introduction Criteria for the Choice of Antimicrobial Agent: Examining the Balance Between Efficacy, Safety, and Tolerability Professor Andy Hoepelman Head of Department of Acute Medicine and Infectious Diseases Professor of...

Introduction Criteria for the Choice of Antimicrobial Agent: Examining the Balance Between Efficacy, Safety, and Tolerability Professor Andy Hoepelman Head of Department of Acute Medicine and Infectious Diseases Professor of...

Defining the Appropriate Critical Pathway for the Treatment of Infectious Diseases: Challenging Drug-Resistant Pathogens (Highlights of a Special Roundtable Discussion)

Introduction Results of the Surveillance of Resistance for Gram-Positive and Gram-Negative Organisms Clyde Thornsberry MRL Pharmaceutical Services, Brentwood, TN, USA Clinical Relevance of In Vitro Resistance: Respiratory Pathogens and Uropathogens Antone A....

Introduction Results of the Surveillance of Resistance for Gram-Positive and Gram-Negative Organisms Clyde Thornsberry MRL Pharmaceutical Services, Brentwood, TN, USA Clinical Relevance of In Vitro Resistance: Respiratory Pathogens and Uropathogens Antone A....

mem_2_1

Quinolones Are Not All the Same: Different Safety Profiles for Specific Compounds (Highlights of a Special Roundtable Discussion)

Introduction History of Quinolones and Their Side Effects Professor Ethan Rubinstein Department of Internal Medicine and Unit of Infectious Diseases, Tel Aviv University School of Medicine, Tel Aviv, Israel Comparison...

Introduction History of Quinolones and Their Side Effects Professor Ethan Rubinstein Department of Internal Medicine and Unit of Infectious Diseases, Tel Aviv University School of Medicine, Tel Aviv, Israel Comparison...

The Treatment of Community-Acquired Pneumonia with Consideration of Mycobacterium Tuberculosis

A meeting of leading Asian experts in respiratory tract infections (RTIs) and tuberculosis (TB) was held on 27th July 2012, in Tokyo, Japan. This meeting brought together clinicians and researchers...

A meeting of leading Asian experts in respiratory tract infections (RTIs) and tuberculosis (TB) was held on 27th July 2012, in Tokyo, Japan. This meeting brought together clinicians and researchers...

Optimizing the Management of Prostatitis: Levofloxacin and Silodosin—Strategies Aimed at Optimal Treatment for Prostatitis

A meeting on the treatment of prostatitis was held on May 5, 2013, in conjunction with the 108th American Urological Association (AUA) Annual Meeting in San Diego. Prostatitis...

A meeting on the treatment of prostatitis was held on May 5, 2013, in conjunction with the 108th American Urological Association (AUA) Annual Meeting in San Diego. Prostatitis...

Optimal Strategic Therapy for Community-Acquired Pneumonia: Levofloxacin at the Forefront of Fluoroquinolone CAP Therapy

A symposium updating the optimal treatment of community-acquired pneumonia (CAP) was held during the APSR 2014 in Bali, Indonesia, November 13–16, 2014. The importance of this session was highlighted...

A symposium updating the optimal treatment of community-acquired pneumonia (CAP) was held during the APSR 2014 in Bali, Indonesia, November 13–16, 2014. The importance of this session was highlighted...

LATEST TOPICS